Conjunctival melanoma.
Conjunctival melanoma is an uncommon tumor that is likely to recur and carries an overall mortality rate of approximately 30%. The seemingly unpredictable and enigmatic character of this entity has initiated much debate over the past decades regarding the etiology, histogenesis, prognosis, and preferred management. This review outlines the historical perspective; incidence and demographics; etiologic factors; histogenesis; cytogenetic findings; clinical characteristics; histopathologic and ultrastructural features; differential diagnoses; classifications; management of primary, recurrent, and systemic disease; survival after conjunctival melanoma; and diverse factors of potential prognostic significance. Finally, a brief outlook on present and future research objectives is provided.
Seregard
S
S
Ophthalmic Pathology and Oncology Service, Saint Eriks Eye Hospital, Stockholm, Sweden.
D000818:Animals; D003131:Combined Modality Therapy; D003230:Conjunctival Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D015994:Incidence; D008545:Melanoma / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate